|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cell tagging with clinically approved iron oxides:feasibility and effect of lipofection,particale size,and surface coating on labeling dfficiency显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，： | 1 |
| 2 | Der neue 1,0-l-dreizylinder MPl-motor fur den up 显示文摘 | Becker N Kirsch U Persigehl K | 2011 | ATZextra ' Der neue VW up!'2011，，： | 1 |
| 3 | Cell tagging with clinically approved iron oxides:feasibility and effect of lipofection,particle size,and surface coating on labeling efficiency显示文摘 | Matuszewski L Persigehl T Wall A etal | 2005 | Radiology2005，235，1： | 1 |
| 4 | Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency 显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，1： | 1 |
| 5 | Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency 显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，： | 1 |
| 6 | Cell tagging with clinically approved iron oxides:feasibility and effect of lipofection,particle size,and surface coating on labeling efficiency显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，： | 1 |
| 7 | Assessment of bone mar- row angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron ox- ides : initial experience 显示文摘 | Matuszewski L Persigehl T Wall A | 2007 | Radiology2007，242，1： | 1 |
| 8 | Cell tagging with clinical approved iron oxides:feasibility and effect of lipofection,particle size and surface coating on labeling efficiency显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，： | 1 |
| 9 | Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，1： | 1 |
| 10 | Cell tagging with clinically approved iron oxides:feasibility and effect of lipofection,particle size,and surface coating on lab eling eficiency显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，： | 1 |
| 11 | Cell tagging with clinically approved iron oxides:feasibility and effect of lipofection,particle size,and surface coating on lab eling efficiency显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，1： | 1 |
| 12 | Oxyfuel coal combustion by efficient integration of oxygen transport membranes显示文摘 | Hannes Stadler Franz Beggel Martin Habermehl Bernhard Persigehl Reinhold Kneer Michael Modigell Peter Jeschke | 2010 | International Journal of Greenhouse Gas Control2010，，1： | 1 |
| 13 | Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides:initial experience显示文摘 | Matuszewski L Persigehl T Wall A | | 0，，01： | 1 |
| 14 | Cell tagging with clinically approved iron oxides:feasibility and effect of lipofection,particle size,and surface coating on labeling efficiency显示文摘 | MATUSZEWSKI L PERSIGEHL T WALL A | 2005 | Radiology2005，235，1： | 1 |
| 15 | Cell tagging with clinically approved iron oxides : feasibility and effect of lipofection, particle size, and surface coating on lab cling efficiency显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，： | 1 |
| 16 | Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF–NGR using multi-modal imaging显示文摘 | Persigehl T Ring J Bremer C | 2014 | Angiogenesis2014，17，1： | 1 |
| 17 | Tissue-factor fusion pro-teins induce occlusion of tumor vessels显示文摘 | Schwoppe C Kessler T Persigehl T | 2010 | Thromb Res2010，125，2： | 1 |
| 18 | Cell tagging with clinically approved iron oxides:feasibility and effect of lipofection,particle size,and surface coating on labeling efficiency显示文摘 | Matuszewski L Persigehl T Wall A | 2005 | Radiology2005，235，1： | 1 |
| 19 | Vessel size imaging(VSI)by robust magnetic resonance(MR)relaxome-try:MR-VSI of solid tumors in correlation with immuno-histology and intravital mi-eroscopy 显示文摘 | Persigehl T Ring J Budny T | 2013 | Mol Imaging2013，12，7： | 1 |
| 20 | Antiangiogenic tumor treatment: early non-invasive monitoring of anti-angiogenic tumor treatment by USPIO enhanced MRI 显示文摘 | Persigehl T Bieker R Matuszewski L | 2007 | Radiolob y2007，244，44： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员